Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

NCT01399086 · clinicaltrials.gov ↗

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Fulvestrant

Sponsor

Hellenic Oncology Research Group